The EBMT activity survey 2009: trends over the past 5 years. - Wikidata - wikimedia - TriplyDB

The EBMT activity survey 2009: trends over the past 5 years.

The EBMT activity survey 2009: trends over the past 5 years.

http://www.wikidata.org/entity/Q51887666

about

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults Bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for haematological malignancies ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.Why has demand for platelet components increased? A review Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries.Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas.Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).Recent advances in treatment of aplastic anemia.Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow Retrospective Analysis of the Blood Component Utilization in a University Hospital of Maximum Medical Care Swiss Blood Stem Cells: More than Just a Registry Screening of related donors and peripheral blood stem cell collection practices at different Italian apheresis centres.Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011 Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines.Allogeneic transplantation: peripheral blood vs. bone marrow.Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.Epigenomics in hematopoietic transplantation: novel treatment strategies.Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision.Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia.Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review.A review of the haematopoietic stem cell donation experience: is there room for improvement?G-CSF-primed BM for allogeneic SCT: revisited.Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?Hematopoietic SCT in Iranian children 1991-2012.First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation gro NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT.Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.A novel approach for the enumeration of peripheral blood stem cells suitable for transplantation Constitutional chromosomal abnormality identified in a sibling donor after bone marrow stem cell transplantation in a pediatric patient with acute megakaryoblastic leukemia.Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.

P2860

Q24195048-EBED302C-CD9E-46E5-80EB-C87DE6679DE0 Q24197741-5497D8F1-06DA-4505-9973-2C82B7E24E52 Q26750395-65861AE1-F938-4344-B140-D2A626517BF9 Q27692619-3CB6F884-9648-4515-9482-DE0115971A8B Q28249969-15424F45-04F0-4B48-B85C-BB68C8A60600 Q31022472-14FD6B99-570B-4BD8-8721-901A1ECDAD67 Q33425816-9AED06A4-28D6-4269-BFC6-2D08650FFC13 Q34330585-E1E21C78-7533-4D6A-B0EF-C3E68643A6D5 Q34451351-628B09B2-D646-4242-977E-CF1BB0755CF4 Q35063668-9F9F9551-21F6-407C-AD5C-DD915A9973D3 Q35673530-D814B1CC-D741-4551-9B4A-822AF77666BE Q35849351-54FB66F5-A139-4516-92F2-DDD1323C6FBA Q35998244-A54134E4-A2EB-4B61-A168-65F151AA784F Q35998257-53C194AF-82AC-40D8-8A30-F5EA3F49D3F5 Q36393487-F2D27179-47ED-4D9F-A5A7-EA53947BA2B6 Q36444449-2A0FBB41-CD78-4434-8A0D-AF155947C26B Q36753274-F4643EA4-8AB2-4A92-AE9B-3A98BBB19FB4 Q36761427-8BEAADBA-7E29-4825-AB8D-BA124FB557E1 Q37060673-500C2CAD-DB31-4E84-8C20-8D7A63FD771F Q37962599-68BEBF10-05A4-44C4-8038-6128D2D3833E Q37996560-F909C503-68F8-4C94-AB61-F339ADD026E7 Q38000901-1475069B-58AD-4B38-B36F-7DAECC453ED7 Q38015268-E05F957D-B1C9-4C32-9B4E-820FD8F3606F Q38025703-D4406044-6603-490D-91E4-24A2C6C9D9B8 Q38040419-FA3D0057-2CCC-450F-88C6-3AE32CC703F7 Q38105131-072B3BCC-F9AC-421A-8DA8-F96AC1FA43A8 Q38181958-7476DD4B-5EAA-47DA-9969-7B5F61F6D2AE Q38366631-BE077239-C317-4766-B2FE-1249C810E6D2 Q38690071-3D7EEBF2-F85E-428C-967F-DE7DF6734B09 Q38785195-B2B184E5-631C-4E81-BFE8-5C9A3AD5B788 Q38832166-C9675B06-B362-4C68-BD59-AB17F67E84F4 Q38952071-A3095588-0431-4E13-9163-50FD3D853B78 Q39054767-5A530D0A-C4BE-42E0-B650-5C8760F2920C Q39400593-499B0A52-D17E-4A1F-95DB-8BAAE33AB32C Q39674459-37E78CAD-365B-4BCE-9AD0-D4E8A49A59CE Q40889684-88ABB00E-4105-4E0A-ABCC-228BD8A583F4 Q41339678-52597CF7-B4A2-41ED-BEA3-F76BCBD71D9A Q42820112-E7270205-CC01-4098-A15D-DF1CA1A00AEC Q43074730-8595C032-6C86-44B4-9ACE-69ADED27A6FF Q43524297-8FE31FF3-9C38-4878-A70B-CFBB9FFF1756

P2860

The EBMT activity survey 2009: trends over the past 5 years.

http://www.wikidata.org/entity/Q51887666

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

The EBMT activity survey 2009: trends over the past 5 years.

@en

The EBMT activity survey 2009: trends over the past 5 years.

@nl

type

label

The EBMT activity survey 2009: trends over the past 5 years.

@en

The EBMT activity survey 2009: trends over the past 5 years.

@nl

prefLabel

The EBMT activity survey 2009: trends over the past 5 years.

@en

The EBMT activity survey 2009: trends over the past 5 years.

@nl

P1433

Q51887666-D889DE7B-B4BA-4AB0-9C14-067626370D53

P1476

Q51887666-1E3A8FDD-57B0-4F87-B159-A4CDC06F710C

P2093

Q51887666-04741D2C-80AD-4890-9C44-2794139DEB85

Q51887666-0917D705-F624-4C60-AD64-65BE0A9AA2F4

Q51887666-3D781BAB-B340-4F04-901C-893EF87C55CE

Q51887666-492DBF9D-3665-43E3-B54A-67DAF3152373

Q51887666-95EBFF2A-5524-4174-A57F-3CFC3A6B1C72

Q51887666-A6A1EAC2-D88F-4911-9C43-41F25A54D0A2

Q51887666-CC6890BF-512D-4A43-940D-DA124F0A656E

Q51887666-E810AE6F-AEEB-4136-BE11-0CDD5A621D5F

P2860

Q51887666-08C5C59D-5680-4620-BD91-FF0493D63907

Q51887666-124C0B14-2FEB-483C-BCC5-972992FC1E01

Q51887666-1D746EAC-E8A7-4542-81E0-41E9C17E5F67

Q51887666-2A470D01-71FA-49B4-BFAC-3F3622BCC26A

Q51887666-379ABDE7-FDF1-4D9B-8C76-FC60E0F85818

Q51887666-4C19A7F8-FF3B-434A-AC3C-99FF12A29DF1

Q51887666-4D0D6CF8-1747-4CEE-A230-D21DCC458AD4

Q51887666-57450FFE-72E0-4061-A2A8-651244DE0C65

Q51887666-638CFC33-BCC8-4B8C-8E45-2DBD07C3E70F

Q51887666-6A05D9A4-C43A-4185-AD68-0ECCC59027DA

P2888

Q51887666-36D1A52D-6276-4826-97EB-6AB9CC96D5BE

P304

Q51887666-4B00FEB1-371E-41A9-B8CA-8B260F5A9567

P31

Q51887666-B0AFCDDC-8ECB-42D2-AF12-164A42971DC5

P356

Q51887666-DBFA66A4-6981-4A71-B3CD-1602C9BF12DD

P407

Q51887666-3CEAC9E6-4230-4733-9AC6-8155C4409776

P433

Q51887666-B7AD29B1-1A32-4386-A68A-D4F11C131B1E

P478

Q51887666-2BE34D2A-C897-4056-AE92-E4D5C15B5EC6

P577

Q51887666-B7AE8245-61AD-4050-B703-FFF0EF63EB84

P5875

Q51887666-CE0CC33A-BD45-4CAC-8E4D-7F03BE0BC856

P6179

Q51887666-0D8DA5E7-3126-416D-A794-329B40F34F6C

P698

Q51887666-E1BBC8D8-07A2-4524-8117-9D488792CCDC

P356

P1433

Bone Marrow Transplantation

P1476

The EBMT activity survey 2009: trends over the past 5 years.

@en

P2093

A Gratwohl

http://www.w3.org/2001/XMLSchema#string

A Madrigal

http://www.w3.org/2001/XMLSchema#string

A Tichelli

http://www.w3.org/2001/XMLSchema#string

D Niederwieser

http://www.w3.org/2001/XMLSchema#string

European Group for Blood and Marrow Transplantation EBMT

http://www.w3.org/2001/XMLSchema#string

H Baldomero

http://www.w3.org/2001/XMLSchema#string

K Frauendorfer

http://www.w3.org/2001/XMLSchema#string

M Gratwohl

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation: a global perspective

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality.

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

Hematopoietic stem-cell transplantation.

A survey on cellular and engineered tissue therapies in europe in 2008.

Bone marrow transplantation for inherited bone marrow failure syndromes.

P2888

P304

485-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2011.11

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50227763

http://www.w3.org/2001/XMLSchema#string

P6179

1029965444

http://www.w3.org/2001/XMLSchema#string

P698

21358689

http://www.w3.org/2001/XMLSchema#string